Troy A. Ignelzi - Insider Trading & Ownership

Location
C/O Esperion Therapeutics, Inc., 46701 Commerce Center Drive, Plymouth, MI
Summary
The estimated net worth of Troy A. Ignelzi is at least $20.1M dollars as of June 26, 2025. Troy A. Ignelzi is the Chief Financial Officer of Karuna Therapeutics, Inc. and owns shares of Karuna Therapeutics, Inc. stock worth about $20M. Troy A. Ignelzi is the Chief Financial Officer of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $99.8K.
Signature
/s/ Peter Slover, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Troy A. Ignelzi

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KRTX Karuna Therapeutics, Inc. Chief Financial Officer $20M Aug 22, 2023
RAPP Rapport Therapeutics, Inc. Chief Financial Officer $99.8K +$101K Mar 12, 2025
CINC CinCor Pharma, Inc. Director Feb 24, 2023
CTNM Contineum Therapeutics, Inc. Director Jun 26, 2025

Insider Transactions Reported by Troy A. Ignelzi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.